COVID-19 Vaccine of US Company Novavax Shows 89.3% Efficacy in Phase 3 Trial in UK - Firm January 28, 2021 Get link Facebook X Pinterest Email Other Apps from UrduPoint News https://ift.tt/3pv69ES Comments
Comments
Post a Comment